* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Pharm - 11-30
Survey
Document related concepts
Drug design wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
NMDA receptor wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
5-HT2C receptor agonist wikipedia , lookup
Toxicodynamics wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Psychopharmacology wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Transcript
ASTHMA AND COPD BY ALAINA DARBY Which of the following is an anti-inflammatory drug? a. Omalizumab b.Montelukast c. Salmeterol d.Epinephrine Which of the following acts on mast cells? a. Budesonide b.Fluticasone c. Cromolyn d.Montelukast What is the purpose of methacholine? a. Muscarinic antagonist used to test for asthma b.Muscarinic agonist used to test for asthma c. Muscarinic antagonist used to treat asthma d.Muscarinic agonist used to treat asthma Which of the following is not a trigger for asthma? a. Environmental exposure b.Food and additives c. Diseases d.Warm air Which is true about the development of asthma? a. Its progression is primarily determined by genetics b.Viral infection during infancy increases incidence of asthma c. Environmental factors are most influential after immune development d.It may further develop into allergies Which of the following is true of asthma attack? a. Bronchospasm occurs late in the attack b.Inflammation is mediated by histamine release by mast cells c. Inflammation is a delayed response d.Bronchospasm is mediated by cytokine signaling Which of the following is true of the progression of asthma? a. Bronchospasm directly causes mucus hypersecretion through smooth muscle constriction b.Tissue edema and shedding of the surface epithelium is due to chronic inflammation c. Chronic inflammation causes remodeling of pulmonary tissue d.Bronchospasm is caused by the activation of adrenergic nerves Which of the following is true of bronchoconstriction? a. Non-asthmatics experience no bronchoconstriction at normal methacholine doses b.Hypersensitivity is an exaggerated response to normal stimulus dose c. Hyperreactivity is an exaggerated response to a high stimulus dose d.A positive reaction is considered to be a 20% rise in FEV1 Which of following is a reason that asthma inhalers are so expensive in the US? a. They no longer use CFC’s as a propellant b.They are no longer under patent c. They have a longer than usual patent d.They are fairly recent medications Which of the following is described by daily inhaler use, two nighttime attacks per week, and a PEF of 75%? a. Intermittent b.Severe c. Mild persistent d.Moderate persistent Which of the following does not promote bronchodilation? a. Adenosine b.Theophylline c. Muscarinic antagonists d.cAMP What is the mechanism of methylxanthines? a. Phosphodiesterase analog b.Promote adenosine c. Inhibit conversion of cAMP to AMP d.Binding adenosine directly Which of the following is true? a. Muscarinic receptors are found in the large bronchioles, beta 2 receptors are found in the small bronchioles b.Muscarinic receptors are found in the large bronchioles, beta 2 receptors are found in the large bronchioles c. Muscarinic receptors are found in the small bronchioles, beta 2 receptors are found in the large bronchioles d.Muscarinic receptors are found in the small bronchioles, beta 2 receptors are found in the small bronchioles Which of the following is true of the location of muscarinic receptors? a. M1 is found in the bronchioles b.M2 is found in the submucosal glands c. M2 is found in the autonomic ganglia d.M3 is found in the submucosal glands Which is not a benefit of using tiotropium over ipratropium? a. It has a shorter onset of action b.It has a longer duration of action c. It is selective for M1 and M3, preventing endogenous Ach release d.It has greater muscarinic receptor affinity Which group of individuals should be cautioned about using ipratropium? a. Those with cancer b.Those with bleeding risk c. Those with BPH d.Those with kidney failure Which of the following is true about drug interactions with beta 2 agonists? a. Saquinavir and diruetics can prolong the effects b.Beta blockers are physiological opposites c. MAOIs and TCAs exacerbate hypokalemia d.Beta blockers can prevent acute bronchospasm treatment Which of the following is a “reliever”? a. Salmeterol b.Albuterol c. Formoterol d.Indacaterol Which of the following is a therapeutic action of albuterol? a. Stabilize mast cells b.Contract smooth muscle c. Block beta receptors d.Reverse hypokalemia Why are glucocorticoids often used in combination with beta agonists? a. They cause additional bronchodilation b.They can also bind to and block the M3 receptors c. They cause upregulation of beta receptors d.They enhance delivery of the beta agonist to its site of action Beta agonists do not work well as bronchodilators in some patients, which of the following is not a reason for this? a. Prolonged use has led to uncoupling from the receptor b.Binding of beta-arrestin has led to internalization of the receptors c. Some patient exhibit SNPs causing diminished activity of the receptor d.Prolonged use has let to damage in the DNA encoding the receptor Which of the following does not stabilize mast cells? a. Albuterol b.Theophylline c. Cromolyn sodium d.Obuzamab Which of the following is a reason continued use of LABAs? a. They cause glucocorticoid receptor upregulation b.They enhance the effects of glucocorticoids c. Bronchoconstriction causes tissue remodeling d.Inflammation can often be prevented by LABA’s Which of the following is a reason for combining SABAs and anticholinergics? a. SABAs cause bronchodilation but anticholinergics do not b.Their receptors are located in different parts of the bronchioles c. They cause synergistic effects when given together d.They are not effective on their own Which of the following is not a potential anti-inflammatory target? a. Nucleus of cytokine producing cells b.The antibodies themselves c. The target cell d.Cytokines themselves Which of the following act directly on the cytokines? a. Cytokine synthesis inhibitors b.Signal transduction inhibitors c. Monoclonal antibodies d.Receptor antagonists How do methylxanthines enhance the effects of beta-2 activation? a. Maintenance of cAMP levels b.Inhibition of adenosine action c. Upregulation of beta-2 receptors d.Enhanced cAMP synthesis Which of the following is not true of cromolyn sodium? a. It stabilizes mast cells b.It produces systemic side-effects c. It has no bronchodilator activity d.It is only for prophylactic use Which of the following is an inhaled steroid? a. Methylprednisone b.Prednisone c. Beclomethasone dipropionate d.Prednisolone Which of the following is not a mechanism through which corticosteroids produce their effects? a. Occupancy of importin alpha b.Increased mucus secretion c. Repression of transcription factors d.Increased anti-inflammatory lipocortins Which of the following produce most of corticosteroid side effects? a. Trans activation b.Lipocortins c. Inflammatory proteins d.GATA-3 Which of the following is true of asthma? a. Neutrophilic asthma is steroid sensitive b.Neutrophilic asthma leads to severe asthma c. Eosinophilic asthma is steroid resistant d.Eosinophilic asthma leads to severe asthma Which of the following would not be a reason for the ineffectiveness of steroids in COPD? a. Changes in binding affinity b.Overexpression of the other form of glucocorticoid receptor c. Decreased cytokine signaling d.Downregulation of histone deacetylase 2 Which of the following is the primary reason for inhaling corticosteroids rather than taking them orally? a. Deliver it directly to the site of action b.Prevent oropharyngeal candidiasis c. Prevent systemic effects d.Avoid first pass metabolism Which of the following would not be a beneficial attribute when developing a steroid? a. Inactive prodrugs b.Reduced excretion c. Dissociated drugs d.Controlled particle size Which of the following is true of the synergism of beta-2 agonists and their effects on corticosteroids? a. They stimulate Gs b.They stimulate Gq c. They stimulate Gi d.They stimulate Gt Which of the following is not a routine test that is necessary for someone taking a combined corticosteroid/LABA? a. Blood glucose b.Serum potassium c. Pulmonary function d.Liver function Which of the following pairs is responsible for leukotriene synthesis? a. COX1/ COX2 b.Phospholipase A2/ thromboxane c. 5 lipoxygenase/ C4 synthetase d.5 lipoxygenase/ thromboxane Which of the following would be a method of treating an individual who is unresponsive to corticosteroids who is experiencing inflammation and bronchospasm? a. Target leukotriene formation as an alternative therapy b.Add beta agonists to enhance corticosteroid response c. Target cyclooxygenase enzyme as an alternative therapy d.Target the neutrophils and eosinophils that mediate the asthmatic response Which is not an indication for members of the “kast” family? a. Asthma b.Exercise-induced bronchospasm c. COPD d.Allergic rhinitis Which of the following is true of the “kast” family? a. They all inhibit CYP2C9 and CYP3A4 b.They cause frequent side effects c. They are a bronchodilator d.They can be given by mouth Which of the following would not be an advantage of antileukotrienes? a. Greater symptom improvement in severe asthma b.Better adherence c. Beneficial benefits in neuronal regulation d.When a beta-2 agonist is contraindicated Which of the following is a leukotriene synthesis blocker? a. Montelukast b.Zileuton c. Theophylline d.Omalizumab Which of the following can cause anaphylaxis and is therefore only administered in a clinical setting? a. Montelukast b.Zileuton c. Theophylline d.Omalizumab Which of the following treatment regimens is the first choice of treatment for intermittent asthma? a. SABA b.LABA c. ICS d.Cromolyn Which of the following is not a treatment for acute asthma? a. Norepinephrine b.Short-acting anticholinergics c. Systemic or inhaled steroids d.MgSO4 Which of the following are the common forms of COPD? a. Asthma and emphysema b.Pneumonia and bronchitis c. Bronchitis and emphysema d.Asthma and pneumonia Which of the following is true of the profile for COPD? a. Younger (children) b.Progressive dyspnea c. Good response to corticosteroids d.Airflow normalizes after episode Which of the following is a drug that is labeled for smoking cessation? a. Varenicline b.Clonidine c. Mecamylamin d.Naltrexone Which of the following is true of nicotine addiction? a. Cigarette smoke only binds to nicotinic receptors in the VTA b.Nicotine initially signals the dopaminergic pathway c. The dopaminergic pathway is quickly desensitized d.Dopamine signaling gives rise to the withdrawal symptoms Which of the following is the mechanism for nicotine replacement therapy? a. Attaining of high levels of nicotine to mimic cigarette response b.Produce sustained plasma nicotine level that is tapered c. Quick accumulation of peak levels d.Induction of the GABA response Which of the following is true of Varenicline? a. Agonist of the α4β2 nicotinic receptor b.Causes the release of mesolimbic dopamine c. Is solely responsible for depressive effects d.One of the most effective single drugs Which of the following is true of Buproprion? a. More effective than varenicline b.Less effective than nicotine replacement c. May cause sedation and depression d.Is a norepinephrine and dopamine reuptake inhibitor Which of the following can be used in conjunction with methylxantines to loosen phlegm and bronchiole secretions? a. Theophylline b.Guaifenesin c. Varenicline d.Roflumilast Which of the following is used only for individuals with severe disease symptoms, reduces the requirement for corticosteroids, and inhibits the PDE enzyme? a. Theophylline b.Guaifenesin c. Varenicline d.Roflumilast Which of the following would not be contraindicated in COPD? a. Sedatives b.Beta-blockers c. Glucocorticoids d.Aspirin e.ACE-inhibitors